Viatris Inc. (VTRS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VTRS Revenue Growth
Revenue Breakdown (FY 2025)
VTRS's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
VTRS Revenue Analysis (2014–2025)
As of May 8, 2026, Viatris Inc. (VTRS) generated trailing twelve-month (TTM) revenue of $14.56 billion, reflecting solid growth of +8.1% year-over-year. The most recent quarter (Q1 2026) recorded $3.52 billion in revenue, down 5.0% sequentially.
Looking at the longer-term picture, VTRS's 5-year compound annual growth rate (CAGR) stands at +3.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $17.89 billion in 2021.
Revenue diversification analysis shows VTRS's business is primarily driven by Brands (64%), and Generics (36%). With over half of revenue concentrated in Brands, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including TEVA (+4.4% YoY), AMRX (+8.0% YoY), and PRGO (-3.6% YoY), VTRS has outperformed the peer group in terms of revenue growth. Compare VTRS vs TEVA →
VTRS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $14.6B | +8.1% | +3.7% | -18.6% | ||
| $17.3B | +4.4% | +0.7% | 12.5% | ||
| $3.0B | +8.0% | +8.7% | -0.2% | ||
| $4.3B | -3.6% | +0.8% | 8.1% | ||
| $62.6B | +1.4% | +8.5% | 24.7% | ||
| $64.9B | +1.2% | +9.4% | 36.2% |
VTRS Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $14.30B | -3.0% | $5.01B | 35.1% | $-2,663,100,000 | -18.6% |
| 2024 | $14.74B | -4.5% | $5.62B | 38.2% | $10.1M | 0.1% |
| 2023 | $15.43B | -5.1% | $6.44B | 41.7% | $766.2M | 5.0% |
| 2022 | $16.26B | -9.1% | $6.50B | 40.0% | $1.61B | 9.9% |
| 2021 | $17.89B | +49.7% | $5.58B | 31.2% | $-34,000,000 | -0.2% |
| 2020 | $11.95B | +3.9% | $3.80B | 31.8% | $-210,800,000 | -1.8% |
| 2019 | $11.50B | +0.6% | $3.90B | 33.9% | $715.5M | 6.2% |
| 2018 | $11.43B | -4.0% | $4.00B | 35.0% | $905.6M | 7.9% |
| 2017 | $11.91B | +7.5% | $4.78B | 40.2% | $1.44B | 12.1% |
| 2016 | $11.08B | +17.5% | $4.70B | 42.4% | $699.2M | 6.3% |
Full VTRS Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See VTRS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VTRS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VTRS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVTRS — Frequently Asked Questions
Quick answers to the most common questions about buying VTRS stock.
Is VTRS's revenue growth accelerating or slowing?
VTRS maintains +8.1% revenue growth, in line with its 5-year CAGR of +3.7%. TTM revenue stands at $14.6B. Growth rate remains consistent with historical average.
What is VTRS's long-term revenue growth rate?
Viatris Inc.'s 5-year revenue CAGR of +3.7% reflects the sustained expansion pattern. Current YoY growth of +8.1% is near this long-term average.
How is VTRS's revenue distributed by segment?
VTRS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.